Inactivation of Slit-Robo Pathway Genes in Cervical Cancer
Author Information
Author(s): Narayan Gopeshwar, Goparaju Chandra, Arias-Pulido Hugo, Kaufmann Andreas M, Schneider Achim, Dürst Matthias, Mansukhani Mahesh, Pothuri Bhavana, Murty Vundavalli V
Primary Institution: Columbia University, New York, NY, USA
Hypothesis
The Slit-Robo pathway genes may be targets of inactivation by a combination of deletion and epigenetic mechanisms in cervical cancer.
Conclusion
The study found a high frequency of promoter hypermethylation of Slit-Robo pathway genes in invasive cervical cancer, suggesting their significant role in cancer progression.
Supporting Evidence
- Promoter hypermethylation of Slit-Robo pathway genes occurs early in tumor progression.
- The study identified a high frequency of promoter hypermethylation in 85% of cervical cancer cases.
- SLIT2 was the most frequently methylated gene, found in 63.9% of tumors.
Takeaway
This study shows that certain genes involved in cell signaling are turned off in cervical cancer, which might help doctors find and treat the disease earlier.
Methodology
The study examined promoter hypermethylation of SLIT1, SLIT2, SLIT3, ROBO1, and ROBO3 genes in cervical cancer samples using methylation-specific PCR.
Limitations
The study did not find significant differences in methylation frequency between cell lines and primary tumors, and further studies are needed to confirm findings in larger cohorts.
Participant Demographics
The study included 119 samples from patients with invasive cervical cancer, with ages ranging from 27 to 85 years.
Statistical Information
P-Value
p<0.025
Statistical Significance
p<0.025
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website